Warfarin use in atrial fibrillation has not increased recently, indicating inadequate implementation of this therapy and a need to address barriers in real-world practice.
Warfarin use in atrial fibrillation has not increased recently, indicating inadequate implementation of this highly effective therapy. Barriers to anticoagulation in real-world clinical practice need to be identified and addressed.
Stafford et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: